UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000009733 |
|---|---|
| Receipt number | R000011410 |
| Scientific Title | A phase 2 study of nab-Paclitaxel followed by FEC (Fluorouracil, Epirubicin, Cyclophosphamide) as primary therapy for operable breast cancer |
| Date of disclosure of the study information | 2013/01/15 |
| Last modified on | 2018/09/18 23:07:59 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/01/09 11:41:00 | ||
| 2 | Update | 2018/09/18 23:07:59 | Recruitment status Publication of results |
